Ubiquitination of NS1 Confers Differential Adaptation of Zika Virus in Mammalian Hosts and Mosquito Vectors
- PMID: 39159062
- PMCID: PMC11497017
- DOI: 10.1002/advs.202408024
Ubiquitination of NS1 Confers Differential Adaptation of Zika Virus in Mammalian Hosts and Mosquito Vectors
Abstract
Arboviruses, transmitted by medical arthropods, pose a serious health threat worldwide. During viral infection, Post Translational Modifications (PTMs) are present on both host and viral proteins, regulating multiple processes of the viral lifecycle. In this study, a mammalian E3 ubiquitin ligase WWP2 (WW domain containing E3 ubiquitin ligase 2) is identified, which interacts with the NS1 protein of Zika virus (ZIKV) and mediates K63 and K48 ubiquitination of Lys 265 and Lys 284, respectively. WWP2-mediated NS1 ubiquitination leads to NS1 degradation via the ubiquitin-proteasome pathway, thereby inhibiting ZIKV infection in mammalian hosts. Simultaneously, it is found Su(dx), a protein highly homologous to host WWP2 in mosquitoes, is capable of ubiquitinating NS1 in mosquito cells. Unexpectedly, ubiquitination of NS1 in mosquitoes does not lead to NS1 degradation; instead, it promotes viral infection in mosquitoes. Correspondingly, the NS1 K265R mutant virus is less infectious to mosquitoes than the wild-type (WT) virus. The above results suggest that the ubiquitination of the NS1 protein confers different adaptations of ZIKV to hosts and vectors, and more importantly, this explains why NS1 K265-type strains have become predominantly endemic in nature. This study highlights the potential application in antiviral drug and vaccine development by targeting viral proteins' PTMs.
Keywords: E3 ligase WWP2; NS1; Zika virus; flavivirus; mosquito; ubiquitination.
© 2024 The Author(s). Advanced Science published by Wiley‐VCH GmbH.
Conflict of interest statement
The authors declare no conflict of interest.
Figures









Similar articles
-
Evolutionary enhancement of Zika virus infectivity in Aedes aegypti mosquitoes.Nature. 2017 May 25;545(7655):482-486. doi: 10.1038/nature22365. Epub 2017 May 17. Nature. 2017. PMID: 28514450 Free PMC article.
-
Zika virus NS5 protein inhibits type I interferon signaling via CRL3 E3 ubiquitin ligase-mediated degradation of STAT2.Proc Natl Acad Sci U S A. 2024 Aug 20;121(34):e2403235121. doi: 10.1073/pnas.2403235121. Epub 2024 Aug 15. Proc Natl Acad Sci U S A. 2024. PMID: 39145933 Free PMC article.
-
TRiC/CCT Complex, a Binding Partner of NS1 Protein, Supports the Replication of Zika Virus in Both Mammalians and Mosquitoes.Viruses. 2020 May 8;12(5):519. doi: 10.3390/v12050519. Viruses. 2020. PMID: 32397176 Free PMC article.
-
Structures of Zika Virus E & NS1: Relations with Virus Infection and Host Immune Responses.Adv Exp Med Biol. 2018;1062:77-87. doi: 10.1007/978-981-10-8727-1_6. Adv Exp Med Biol. 2018. PMID: 29845526 Review.
-
Potential for Zika Virus to Establish a Sylvatic Transmission Cycle in the Americas.PLoS Negl Trop Dis. 2016 Dec 15;10(12):e0005055. doi: 10.1371/journal.pntd.0005055. eCollection 2016 Dec. PLoS Negl Trop Dis. 2016. PMID: 27977671 Free PMC article. Review.
Cited by
-
Towards a Universal Translator: Decoding the PTMs That Regulate Orthoflavivirus Infection.Viruses. 2025 Feb 19;17(2):287. doi: 10.3390/v17020287. Viruses. 2025. PMID: 40007042 Free PMC article. Review.
-
E3 ubiquitin ligase MARCH5 positively regulates Japanese encephalitis virus infection by catalyzing the K27-linked polyubiquitination of viral E protein and inhibiting MAVS-mediated type I interferon production.mBio. 2025 Apr 9;16(4):e0020825. doi: 10.1128/mbio.00208-25. Epub 2025 Mar 12. mBio. 2025. PMID: 40071916 Free PMC article.
-
Mechanisms and Research Methods of Protein Modification in Virus Entry.Appl Biochem Biotechnol. 2025 Jul 19. doi: 10.1007/s12010-025-05333-x. Online ahead of print. Appl Biochem Biotechnol. 2025. PMID: 40682621 Review.
References
-
- Wu P., Yu X., Wang P., Cheng G., Expert Rev. Mol. Med. 2019, 21, e1. - PubMed
-
- a) Santos A. L., Lindner A. B., Oxid. Med. Cell Longev. 2017, 2017, 5716409; - PMC - PubMed
- b) Rahnefeld A., Klingel K., Schuermann A., Diny N. L., Althof N., Lindner A., Bleienheuft P., Savvatis K., Respondek D., Opitz E., Ketscher L., Sauter M., Seifert U., Tschöpe C., Poller W., Knobeloch K. P., Voigt A., Circulation 2014, 130, 1589; - PubMed
- c) Zhang T., Ye Z., Yang X., Qin Y., Hu Y., Tong X., Lai W., Ye X., Sci. Rep. 2017, 7, 43691. - PMC - PubMed
MeSH terms
Substances
Grants and funding
- Priority Academic Program Development of Jiangsu Higher Education Institutions
- 81971917/National Natural Science Foundation of China
- 32170142/National Natural Science Foundation of China
- 2023-I2M-2-010/CAMS Initiation Fund for Medical Sciences
- 2022-I2M-2-004/CAMS Initiation Fund for Medical Sciences
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous